![Novartis announces FDA approval for JadenuTM to simplify treatment administration for patients with chronic iron overload Novartis announces FDA approval for JadenuTM to simplify treatment administration for patients with chronic iron overload](https://www.multivu.com/players/English/7440151-novartis-jadenu-fda-approval/gallery//image/fedd809c-aef5-439d-9e40-b80f69a581f2.jpg)
Novartis announces FDA approval for JadenuTM to simplify treatment administration for patients with chronic iron overload
TAJ PHARMA Product Gallery - Deferasirox Dispersible Tablets 250mg (DEFRATAJ) Taj Pharma DefraTaj is also indicated for the treatment of chronic iron overload requiring chelation therapy when deferoxamine therapy is contraindicated or
![Novartis announces FDA approval for JadenuTM to simplify treatment administration for patients with chronic iron overload Novartis announces FDA approval for JadenuTM to simplify treatment administration for patients with chronic iron overload](https://www.multivu.com/players/English/7440151-novartis-jadenu-fda-approval/gallery//image/761bfd65-adac-4f1c-a96a-8ca2873ef93f.jpg)